Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,275.00
Bid: 2,250.00
Ask: 2,300.00
Change: -25.00 (-1.09%)
Spread: 50.00 (2.222%)
Open: 2,295.00
High: 2,295.00
Low: 2,275.00
Prev. Close: 2,300.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Long Term Incentive Plan Awards

19 Nov 2021 14:46

RNS Number : 0153T
Craneware plc
19 November 2021
 

 

Craneware plc

("Craneware" or the "Company")

 

Grant of Long Term Incentive Plan Awards

 

19 November 2021 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that on 18 November 2021, under the terms of the Craneware plc Long Term Incentive Plan (2016) ("LTIP"), a conditional award of ordinary shares of 1p each in the Company ("Shares") was granted to two Directors of the Company as follows:

 

Director

No. of Shares over which a conditional share award was granted

Percentage of issued share capital

Keith Neilson (CEO)

24,896

0.07%

Craig Preston (CFO)

18,505

0.05%

 

The awards will ordinarily vest after three years subject to:

 

(i) the satisfaction of certain performance conditions based on the Company's total shareholder return ("TSR") performance relative to the performance achieved by the constituent companies within the FTSE AIM 100 Index; and

(ii) the Director's continued employment.

 

The performance conditions are measured in three tranches such that one third of the Shares over which the LTIP awards subsist will vest based on performance over the three years ending on 30 June 2022, one third based on performance over the three years ending 30 June 2023 and the final third based on performance over the three years to 30 June 2024 - an aggregate five year period. Any tranche (or part thereof) that does not meet the performance criteria will lapse.

 

If and to the extent that these LTIP awards vest, the resulting (net of tax) Shares will be subject to a two year holding period.

 

There was no consideration for the grant of the LTIP awards and no consideration will be payable by the award holders to receive the Shares from these LTIP awards, if and to the extent that they vest. 

 

 

PDMR notification: Keith Neilson

 

1. Details of the Restricted Person / person closely associated with him or her

a) Name Keith Neilson

 

2. Reason for the notification

a) Position / status CEO

b) Initial notification / Amendment Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Grant of conditional share award under the Craneware plc

Long Term Incentive Plan (2016)

 

d) Price(s) and volume(s) Volume(s) granted 24,896, Price(s) £0

 

e) Aggregated information:

i. Aggregated volume Aggregate volume granted 24,896 

ii. Price Price(s) £0

 

f) Date of the transaction 2021-11-18

 

g) Place of the transaction Outside a trading venue

 

PDMR notification: Craig Preston

 

1. Details of the Restricted Person / person closely associated with him or her

a) Name Craig Preston

 

2. Reason for the notification

a) Position / status CFO

b) Initial notification / Amendment Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Grant of conditional share award under the Craneware plc

Long Term Incentive Plan (2016)

 

d) Price(s) and volume(s) Volume(s) granted 18,505, Price(s) £0

 

e) Aggregated information:

i. Aggregated volume Aggregate volume granted 18,505

ii. Price Price(s) £0

 

f) Date of the transaction 2021-11-18

 

g) Place of the transaction Outside a trading venue

 

 

 

For further information, please contact:

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO

 

Craig Preston, CFO

 

 

 

Alma (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Hilary Buchanan, Joe Pederzolli

craneware@almapr.co.uk

 

 

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Dan Webster, George Sellar, Andrew Clark

 

 

 

Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Sebastian Lawrence

 

  

 

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Jack Botros, Alix Mecklenburg-Solodkoff

 

 

 

About Craneware

 

We at the Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organizations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for U.S. healthcare providers.

 

Our combined suite of applications and industry-leading team of experts help our customers contextualize operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence - something no other single partner can provide.

 

Together, approximately 40% of registered U.S. hospitals are now our customers, including more than 2000 U.S hospitals and health systems and almost 10,000 clinics and retail pharmacies. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.

 

Learn more at craneware.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFDFLUEFSELF
Date   Source Headline
28th May 20124:11 pmRNSHolding(s) in Company
8th May 20125:41 pmRNSHolding(s) in Company
27th Apr 20125:09 pmRNSHolding(s) in Company
26th Apr 20124:17 pmRNSHolding(s) in Company
26th Apr 20123:46 pmRNSHolding(s) in Company
23rd Apr 20126:14 pmRNSTotal Voting Rights
23rd Apr 20126:13 pmRNSBlocklisting Interim Review
16th Apr 201212:57 pmRNSHolding(s) in Company
30th Mar 201212:36 pmRNSHolding(s) in Company
29th Mar 20125:02 pmRNSHolding(s) in Company
28th Mar 20123:39 pmRNSHolding(s) in Company
20th Mar 201212:12 pmRNSHolding(s) in Company
12th Mar 20125:51 pmRNSDividend Currency Election
8th Mar 201212:57 pmRNSHolding(s) in Company
5th Mar 201212:17 pmRNSTotal Voting Rights
2nd Mar 20123:24 pmRNSHolding(s) in Company
29th Feb 20125:43 pmRNSHolding(s) in Company
28th Feb 20124:29 pmRNSDirector/PDMR Shareholding
28th Feb 20127:00 amRNSChannel Partner Contract Win
28th Feb 20127:00 amRNSHalf Yearly Report
17th Feb 20123:29 pmRNSHolding(s) in Company
1st Feb 20127:00 amRNSNotice of Results
31st Jan 201210:00 amRNSHolding(s) in Company
16th Jan 20123:40 pmRNSHolding(s) in Company
12th Jan 20126:28 pmRNSHolding(s) in Company
11th Jan 20124:55 pmRNSHolding(s) in Company
10th Jan 20127:00 amRNSTrading Update
11th Nov 20111:14 pmRNSDividend Currency Election
10th Nov 201110:36 amRNSResult of AGM
10th Nov 20117:00 amRNSAGM Statement
1st Nov 20115:39 pmRNSTotal Voting Rights
1st Nov 201112:29 pmRNSBlocklisting Interim Review
25th Oct 20111:42 pmRNSDirector/PDMR Shareholding
18th Oct 20112:26 pmRNSPosting of Annual Report & Notice of AGM
30th Sep 20114:43 pmRNSTotal Voting Rights
26th Sep 20117:00 amRNSGrant of Options
31st Aug 201111:53 amRNSDirector/PDMR Shareholding
30th Aug 20117:00 amRNSFinal Results
22nd Aug 20115:02 pmRNSHolding(s) in Company
22nd Aug 20114:40 pmRNSSecond Price Monitoring Extn
22nd Aug 20114:35 pmRNSPrice Monitoring Extension
19th Aug 20114:40 pmRNSSecond Price Monitoring Extn
19th Aug 20114:35 pmRNSPrice Monitoring Extension
11th Aug 20113:49 pmRNSHolding(s) in Company
19th Jul 20117:00 amRNSTrading Update and Contract Wins
2nd Jun 20117:00 amRNSInvestor and Analyst Presentation
2nd Jun 20117:00 amRNSCraneware InSight Contract Win
31st May 201112:24 pmRNSTotal Voting Rights
24th May 20117:00 amRNSDirector Declaration
28th Apr 20112:42 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.